Screening for Atrial Fibrillation
Table of contents
Atrial Fibrillation
- 2020 ESC Guidelines: includes the ‘diagnostic criteria for atrial fibrillation’ in Section 3.2.
- 2021 NICE Guideline: includes the recommendation that ‘12?lead ECG should be used as the test to confirm atrial fibrillation, to prevent the use of less accurate ECG devices, such as mobile and lead?I ECG devices’.
- Responsible for a fivefold increase in stroke risk
Screening Studies
STROKESTOP Study
Websites:
Study Design:
Results:
- Screening (before follow-up)
- Follow-up outcomes, and accompanying Comment.
- Geographic and socio-demographic differences in uptake of screening
- Automated ECG analysis algorithm
- Cost-effectiveness
Follow-up study:
STROKESTOP II Study
Websites:
Study Design:
Results:
SAFER Study
Websites:
Protocols:
Papers:
- Feasibility Study Results
- Embedding qualitative research in trials
- Why do people take part in atrial fibrillation screening?
Engineering Analyses:
- Algorithm tags and number of reviewers: initial results
- Prioritising ECGs for manual review
- Characterising RR-intervals
LOOP Study
Results:
- Follow-up outcomes, and accompanying Comment.
SCREEN-AF Study
Websites:
Results:
REHEARSE-AF Study
Results:
PULsE-AI Trial
Results:
AF Detection Studies
Apple Heart Study
FitBit Heart Study
Devices
Zenicor’s handheld ECG device
- Website, including Press images
AliveCor’s Kardia Mobile device
Withings wrist-watch devices
Cardiolund’s ECG Parser algorithm
Context
- Healthcare provider views on devices
- Systematic review and economic evaluation of lead-I ECG devices
Context
Single-time point screening
ECG-based AF screening
Reviews of screening for AF
- Population-based screening for atrial fibrillation - see Table 4 for a list of ongoing studies.
- Screening for atrial fibrillation: A call for evidence
- Screening for atrial fibrillation